Further analysis revealed that ASAP2 also exhibited higher expression levels in other types of malignancies, such as cholangiocarcinoma, head and neck squamous cell carcinoma, and lung squamous cell carcinoma (Additional file 1: Fig. S1D). This evidence concerns the gene ASAP2 and head and neck squamous cell carcinoma.